Increased plasma DR‐70 (fibrinogen‐fibrin degradation products) concentrations as a diagnostic biomarker in dogs with neoplasms
CH Ke, KM Sio, CH Wu, YY Xia, JJ Lee… - Journal of Veterinary …, 2023 - Wiley Online Library
Background Tumor biomarkers have used widely in clinical oncology in human medicine.
Only a few studies have evaluated the clinical utility of tumor biomarkers for veterinary …
Only a few studies have evaluated the clinical utility of tumor biomarkers for veterinary …
DR-70 (fibrinogen-fibrin degradation products) as a prognostic biomarker in dogs with neoplasms
CH Ke, CS Lin, KM Sio, CH Wu, YY Xia, JJ Lee… - Veterinary …, 2024 - Taylor & Francis
Fibrinogen–fibrin degradation products (DR-70) are derived from tumor cells or metastases.
Our previous study reported the diagnostic values in dogs with tumors, but no research has …
Our previous study reported the diagnostic values in dogs with tumors, but no research has …
[PDF][PDF] The Prognostic and Predictive role of DR70 immunoassay in Patients with Advanced (Metastatic) Breast Cancer
S Koca, NA Babacan, IN Okten, TA Telli, O Ala… - Chemotherapy, 2023 - ejmi.org
Objectives: DR-70 is a newly developed immunoassay that detects fibrin degradation
products in blood. To the best of our knowledge, no previous study has investigated the …
products in blood. To the best of our knowledge, no previous study has investigated the …